EDESA BIOTECH, INC. Operating Cash Flow
EDESA BIOTECH, INC. (EDSA) reported Operating Cash Flow of -$7.19 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- EDESA BIOTECH, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$3.08M.
- EDESA BIOTECH, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.02M.
- EDESA BIOTECH, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$2.09M.
- EDESA BIOTECH, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.72M.
- EDESA BIOTECH, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$7.32M.
- EDESA BIOTECH, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$4.89M.
- EDESA BIOTECH, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$6.64M.
- EDESA BIOTECH, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$12.28M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-13 | -$5.10M derived: sum of 2 quarters · filed 2026-08-13 | -$7.19M 10-Q · filed 2026-08-13 | -$8.91M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | -$2.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-14 | -$4.10M 10-Q · filed 2026-05-14 | -$5.82M derived: sum of 3 quarters · filed 2026-05-14 | -$7.53M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | -$2.09M 10-Q · filed 2026-02-13 | -$3.81M derived: sum of 2 quarters · filed 2026-02-13 | -$5.51M derived: sum of 3 quarters · filed 2026-08-13 | -$7.89M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-09-30 | -$1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | -$3.42M derived: sum of 2 quarters · filed 2026-08-13 | -$5.81M derived: sum of 3 quarters · filed 2026-08-13 | -$7.32M 10-K · filed 2025-12-12 | ||
| 2025-06-30 | -$1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-13 | -$4.08M derived: sum of 2 quarters · filed 2026-08-13 | -$5.60M 10-Q · filed 2026-08-13 | -$6.57M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | -$2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-14 | -$3.90M 10-Q · filed 2026-05-14 | -$4.87M derived: sum of 3 quarters · filed 2026-05-14 | -$5.72M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | -$1.52M 10-Q · filed 2026-02-13 | -$2.48M derived: sum of 2 quarters · filed 2026-02-13 | -$3.34M derived: sum of 3 quarters · filed 2026-02-13 | -$5.00M derived: sum of 4 quarters · filed 2026-02-13 | ||
| 2024-09-30 | -$967.04K derived: 10-K 12 month − 10-Q 9 month · filed 2025-12-12 | -$1.82M derived: sum of 2 quarters · filed 2025-12-12 | -$3.48M derived: sum of 3 quarters · filed 2025-12-12 | -$4.89M 10-K · filed 2025-12-12 | ||
| 2024-06-30 | -$856.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-08 | -$2.52M derived: sum of 2 quarters · filed 2025-08-08 | -$3.92M 10-Q · filed 2025-08-08 | -$5.39M derived: sum of 4 quarters · filed 2025-08-08 | ||
| 2024-03-31 | -$1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | -$3.07M 10-Q · filed 2025-05-14 | -$4.53M derived: sum of 3 quarters · filed 2025-05-14 | -$6.34M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$1.41M 10-Q · filed 2025-02-14 | -$2.87M derived: sum of 2 quarters · filed 2025-02-14 | -$4.68M derived: sum of 3 quarters · filed 2025-02-14 | -$6.25M derived: sum of 4 quarters · filed 2025-02-14 | ||
| 2023-09-30 | -$1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-12-13 | -$3.27M derived: sum of 2 quarters · filed 2024-12-13 | -$4.85M derived: sum of 3 quarters · filed 2024-12-13 | -$6.64M 10-K · filed 2024-12-13 | ||
| 2023-06-30 | -$1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | -$3.38M derived: sum of 2 quarters · filed 2024-08-09 | -$5.17M 10-Q · filed 2024-08-09 | -$10.80M derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | -$1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-10 | -$3.36M 10-Q · filed 2024-05-10 | -$8.99M derived: sum of 3 quarters · filed 2024-05-10 | -$12.02M derived: sum of 4 quarters · filed 2024-05-10 | ||
| 2022-12-31 | -$1.79M 10-Q · filed 2024-02-09 | -$7.42M derived: sum of 2 quarters · filed 2024-02-09 | -$10.45M derived: sum of 3 quarters · filed 2024-02-09 | -$10.86M derived: sum of 4 quarters · filed 2024-02-09 | ||
| 2022-09-30 | -$5.63M derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-15 | -$8.66M derived: sum of 2 quarters · filed 2023-12-15 | -$9.07M derived: sum of 3 quarters · filed 2023-12-15 | -$12.28M 10-K · filed 2023-12-15 | ||
| 2022-06-30 | -$3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-09 | -$3.44M derived: sum of 2 quarters · filed 2023-08-09 | -$6.65M 10-Q · filed 2023-08-09 | -$7.01M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | -$416.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-11 | -$3.62M 10-Q · filed 2023-05-11 | -$3.98M derived: sum of 3 quarters · filed 2023-05-11 | -$7.10M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$3.21M 10-Q · filed 2023-02-10 | -$3.56M derived: sum of 2 quarters · filed 2023-02-10 | -$6.68M derived: sum of 3 quarters · filed 2023-02-10 | -$13.86M derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-09-30 | -$355.32K derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-16 | -$3.47M derived: sum of 2 quarters · filed 2022-12-16 | -$10.65M derived: sum of 3 quarters · filed 2022-12-16 | -$13.66M 10-K · filed 2022-12-16 | ||
| 2021-06-30 | -$3.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-12 | -$10.30M derived: sum of 2 quarters · filed 2022-08-12 | -$13.31M 10-Q · filed 2022-08-12 | -$14.98M derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | -$7.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | -$10.19M 10-Q · filed 2022-05-13 | -$11.86M derived: sum of 3 quarters · filed 2022-05-13 | -$13.22M derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | -$3.01M 10-Q · filed 2022-02-14 | -$4.68M derived: sum of 2 quarters · filed 2022-02-14 | -$6.04M derived: sum of 3 quarters · filed 2022-02-14 | -$7.21M derived: sum of 4 quarters · filed 2022-02-14 | ||
| 2020-09-30 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-28 | -$3.03M derived: sum of 2 quarters · filed 2021-12-28 | -$4.20M derived: sum of 3 quarters · filed 2021-12-28 | -$4.99M 10-K · filed 2021-12-28 | ||
| 2020-06-30 | -$1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | -$2.52M derived: sum of 2 quarters · filed 2021-08-13 | -$3.31M 10-Q · filed 2021-08-13 | -$4.64M derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | -$1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-14 | -$1.96M 10-Q · filed 2021-05-14 | -$3.29M derived: sum of 3 quarters · filed 2021-05-14 | -$6.41M derived: sum of 4 quarters · filed 2021-05-14 | ||
| 2019-12-31 | -$789.71K 10-Q · filed 2021-02-16 | -$2.12M derived: sum of 2 quarters · filed 2021-02-16 | -$5.24M derived: sum of 3 quarters · filed 2021-02-16 | -$5.63M derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2019-09-30 | -$1.33M derived: 10-K 9 month − 10-Q 6 month · filed 2020-12-07 | -$4.45M derived: sum of 2 quarters · filed 2020-12-07 | -$4.85M 10-K · filed 2020-12-07 | -$5.23M derived: sum of 4 quarters · filed 2020-12-07 | ||
| 2019-06-30 | -$3.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-12 | -$3.52M 10-Q · filed 2019-08-14 | -$3.90M 10-Q · filed 2020-08-12 | -$4.87M derived: sum of 4 quarters · filed 2020-08-12 | ||
| 2019-03-31 | -$398.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-15 | -$781.23K 10-Q · filed 2020-05-15 | -$2.53M 10-Q · filed 2019-05-08 | -$1.75M derived: sum of 3 quarters · filed 2020-05-15 | -$2.86M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | -$382.35K 10-Q · filed 2020-02-13 | -$1.31M 10-Q · filed 2019-02-05 | -$1.35M derived: sum of 2 quarters · filed 2020-02-13 | -$2.46M derived: sum of 3 quarters · filed 2020-02-13 | -$1.29M 10-KT · filed 2019-12-12 | |
| 2018-09-30 | -$971.23K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | -$2.08M derived: sum of 2 quarters · filed 2018-11-30 | -$3.47M derived: sum of 3 quarters · filed 2019-05-08 | -$4.62M 10-K · filed 2018-11-30 | ||
| 2018-06-30 | -$1.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | -$687.97K 10-Q · filed 2019-08-14 | -$3.64M 10-Q · filed 2018-08-08 | -$4.76M derived: sum of 4 quarters · filed 2019-05-08 | ||
| 2018-03-31 | -$1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08 | -$2.53M 10-Q · filed 2019-05-08 | -$3.65M derived: sum of 3 quarters · filed 2019-05-08 | -$4.59M derived: sum of 4 quarters · filed 2019-05-08 | ||
| 2017-12-31 | -$1.14M 10-Q · filed 2019-02-05 | -$2.26M derived: sum of 2 quarters · filed 2019-02-05 | -$3.20M derived: sum of 3 quarters · filed 2019-02-05 | -$4.48M derived: sum of 4 quarters · filed 2019-02-05 | ||
| 2017-09-30 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30 | -$2.06M derived: sum of 2 quarters · filed 2018-11-30 | -$3.33M derived: sum of 3 quarters · filed 2018-11-30 | -$4.70M 10-K · filed 2018-11-30 | ||
| 2017-06-30 | -$941.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08 | -$2.22M derived: sum of 2 quarters · filed 2018-08-08 | -$3.58M 10-Q · filed 2018-08-08 | |||
| 2017-03-31 | -$1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-07 | -$2.64M 10-Q · filed 2018-05-07 | ||||
| 2016-12-31 | -$1.37M 10-Q · filed 2018-02-07 | |||||
| 2016-09-30 | -$4.51M 10-K · filed 2017-12-01 | |||||
| 2015-09-30 | -$4.41M 10-K · filed 2017-12-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |